DÍVIDA Alterar Data
AbbVie USD 72.86B 5.36B 2026-03
Agenus USD 35.54M 2.34M 2025-03
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
Ardelyx USD 208.26M 653K 2026-03
aTyr Pharma USD 1.81M 29K 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Celldex Therapeutics USD 1.91M 428K 2026-03
Curis USD 0 0 2022-06
Eli Lilly USD 43.37B 867M 2026-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Incyte USD 38.27M 1.16M 2026-06
MacroGenics USD 36.51M 500K 2026-03
Novartis USD 49.01B 2.02B 2026-06
Novartis USD 47B 14.98B 2026-03
Pfizer USD 63.19B 536M 2026-06
Prothena USD 7.65M 1.43M 2026-03
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06